SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-001909 from American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)

American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
Date: Jan. 6, 2023 · CIK: 0001839998 · Accession: 0001104659-23-001909

AI Filing Summary & Sentiment

Date
January 6, 2023
Author
/s/ Jonathan Ko
Form
CORRESP
Company
American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)

Letter

Re: Digital Transformation Opportunities Corp.

January 6, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Preliminary Proxy Statement

Ladies and Gentlemen:

On behalf of our client, Digital Transformation Opportunities Corp. (the “Company”), the Company is filing with the Securities and Exchange Commission a preliminary proxy statement relating to the Company’s proposed business combination with American Oncology Network, LLC (the “Proxy Statement”).

Please contact Jonathan Ko of Paul Hastings LLP, counsel to the Company, by phone at (213) 683-6188 or by email at jonathanko@paulhastings.com regarding the Proxy Statement.

Very truly yours,
/s/ Jonathan Ko

Show Raw Text
CORRESP
1
filename1.htm

January 6, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:           Digital
Transformation Opportunities Corp.

Preliminary Proxy Statement

Ladies and Gentlemen:

On behalf
of our client, Digital Transformation Opportunities Corp. (the “Company”), the Company is filing with the Securities and Exchange
Commission a preliminary proxy statement relating to the Company’s proposed business combination with American Oncology Network,
LLC (the “Proxy Statement”).

Please contact Jonathan Ko of Paul Hastings LLP,
counsel to the Company, by phone at (213) 683-6188 or by email at jonathanko@paulhastings.com regarding the Proxy Statement.

  Very truly yours,

  /s/ Jonathan Ko

  Jonathan Ko

  Paul Hastings LLP

cc:            Kevin
Nazemi, Digital Transformation Opportunities Corp.

David Gould, American Oncology Network, LLC

David Hernand, Paul Hastings LLP

Sahand Moarefy, Paul Hastings LLP

Brian Lee, Dentons US LLP

Ilan Katz, Dentons US LLP